Edit |   |
---|---|
Antigenic Specificity | CD38, Human (Daratumumab biosimilar) |
Clone | Daratumumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | WB, IP, IF, FuncS, FCM, Neut, ELISA |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD38 Recombinant Antibody (Daratumumab). Daratumumab, sold under the brand name Darzalex, is an anti-cancer medication. It binds to CD38, which is overexpressed in multiple myeloma cells. Daratumumab was originally developed by Genmab, but it is now being jointly developed by Genmab along with the Johnson & Johnson subsidiary Janssen Biotech, which acquired worldwide commercialization rights to the drug from Genmab. |
Immunogen | n/a |
Other Names | Anti-CD38 Recombinant Antibody, Research Grade Daratumumab, Anti-Human CD38 Recombinant Antibody(Daratumumab), HuMax-CD38, Antibody Drug Analogues, Monoclonal Antibody, YR1199, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 945721-28-8 |
Catalog # | YR1199 |
Price | please inquire |
Order / More Info | CD38, Human (Daratumumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |